Jennifer Woyach, MD
Dr. Jennifer A. Woyach is a Professor in the Division of Hematology in the Department of Internal Medicine at The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute. She is the D Warren Brown Chair of Leukemia Research, the Associate Director for Clinical Research in the Division of Hematology and Section Head for the CLL/hairy cell leukemia group, and also serves as co-Director of the Leukemia Research Program within the OSU Comprehensive Cancer Center.
Dr. Woyach earned her medical degree from The Ohio State University College of Medicine and Public Health, where she also completed a residency in internal medicine, serving as Chief Resident in her final year. Afterwards, she remained at The Ohio State University to complete a fellowship in hematology and medical oncology and joined the faculty in 2012.
Dr. Woyach's research interests include chronic lymphocytic leukemia (CLL) and other hematologic malignancies. Her laboratory research focuses on the role of Bruton's Tyrosine Kinase (BTK) in the development and expansion of CLL, as well as therapeutic BTK inhibition in CLL using murine and cellular models. Her research also examines resistance to BTK inhibitor therapy. Her clinical research focuses on novel agents in CLL. She is the PI for multiple early stage clinical trials investigating novel targeted therapies for CLL and other hematologic malignancies, and also mentor junior faculty members in the development and conduct of Phase I studies.
Among her achievements, Dr. Woyach is a recipient of the 2015 American Society for Clinical Investigation Young Physician-Scientist Award. Her work has been featured in several medical publications, including NEJM, Journal of Clinical Oncology, Lancet Oncology, Blood and Cancer Discovery. She is a member of the leukemia committee of the Alliance for clinical trials in oncology, the women in hematology subcommittee of ASH, and is a standing member of the iwCLL.